Websitewww.sunwaybiotech.com
www.sunwaybiotech.com
www.sunwaybiotech.comDRUG FACTS:
- Manufacturer
- Liddell Laboratories, Inc. | Apotheca Company
- Effective date
- 2026-05-15
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- full-release
- Hydrated at
- 2026-06-01 02:38:41
Label at a glance#
ProductBrain Power
Active ingredientARNICA MONTANA, PORK BRAIN, SILYBUM MARIANUM SEED, CINCHONA OFFICINALIS BARK, GINKGO, SOMATROPIN, LECITHIN, SOYBEAN, ACHILLEA MILLEFOLIUM, PHOSPHORIC ACID, SILICON DIOXIDE, ZINC SULFATE HEPTAHYDRATE, SACCHAROMYCES CEREVISIAE RNA
Label structure9 sections
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
ACTIVE INGREDIENTS: Arnica montana 3X, Brain suis 6X, Carduus marianus 3X, Cinchona officinalis 6X, Ginkgo biloba 6X, HGH 30X, Lecithin 12X, Millefolium 3X, Phosphoricum acidum 30C, RNA 6C, Silicea 12X, Zincum sulphuricum 12X.
OTC - PURPOSE SECTION
INDICATIONS: Relieves symptoms of aging or a rundown condition, including: Lapses in ability to remember facts, names, people, words; Feeling of confusion or difficulty in collecting one's thoughts; Short attention span; Mental exhaustion; Poor mood.
WARNINGS SECTION
WARNINGS: Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Stop use and ask doctor is symptoms persist, worsen or if new symptoms occur.
If pregnant or breast-feeding, ask a health professional before use.
Do not use if TAMPER EVIDENT seal around neck of bottle is broken or missing.
DOSAGE & ADMINISTRATION SECTION
DIRECTIONS: Adults only: Spray twice under the tongue, three times a day. This bottle contains about one month supply. The bottle contains 180 sprays (6 sprays per day for 30 days).
INACTIVE INGREDIENT SECTION
INACTIVE INGREDIENTS: Alcohol 9% v/v, Glycerin 10% v/v. Purified water.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
KEEP OUT OF REACH OF CHILDREN. In case of overdose, get medical help or contact a Poison Control Center right away.
INDICATIONS & USAGE SECTION
INDICATIONS: Relieves symptoms of aging or a rundown condition, including: Lapses in ability to remember facts, names, people, words; Feelings of confusion or difficulty in collecting one's thoughts; Short attention span; Mental exhaustion; Poor mood.
OTC - QUESTIONS SECTION
MADE IN U.S.A.
Dist. By:
SUNWAY BIOTECH INTERNATIONAL, LLC
8632 Archibald Ave.
Rancho Cucamonga, CA 91730
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
BRAIN POWER
with
Recombinant HGH
HOMEOPATHIC
FAST ACTING ORAL SPRAY
1.0 FL OZ (30 ML)
SUNWAY BIOTECH
SCIENTIFICALLY TESTED
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| f47a510b-6679-4664-b2d6-47b5c4afe7cc | Product name | 4 | 20260217 |
| 79c101e4-e5e3-43d7-be20-f7477d1e7556 | Product name | 1 | 20241230 |
| 0306390c-dd77-4363-afe0-63c58088b2a1 | Product name | 1 | 20220120 |
| 503ea967-4b9c-48cf-9e87-c7975295849d | Product name | 2 | 20220120 |
| 34b7b043-6d89-4d95-9bed-7f5f2b49e6ef | Product name | 2 | 20200325 |
| 37e0ae3d-ccb0-0ec8-fae8-e1f0917a8a04 | Product name | 2 | 20200325 |
| 739a54c2-5f56-495a-aa67-4295fbc1cc86 | Product name | 2 | 20200325 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 50845-0056-1 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-c19a-8e05-e053-dbdaa90a074a | DRUG FACTS: |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50845-0056-1 | Brain Power | 30 mL in 1 BOTTLE, SPRAY | SPRAY | 30 | 2 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ACHILLEA MILLEFOLIUM | ACTIVE INGREDIENT | 2FXJ6SW4PK | 1 | |
| ARNICA MONTANA | ACTIVE INGREDIENT | O80TY208ZW | 1 | |
| CINCHONA OFFICINALIS BARK | ACTIVE INGREDIENT | S003A158SB | 1 | |
| GINKGO | ACTIVE INGREDIENT | 19FUJ2C58T | 1 | |
| LECITHIN, SOYBEAN | ACTIVE INGREDIENT | 1DI56QDM62 | 1 | |
| PHOSPHORIC ACID | ACTIVE INGREDIENT | E4GA8884NN | 1 | |
| PORK BRAIN | ACTIVE INGREDIENT | 466251J72G | 1 | |
| SACCHAROMYCES CEREVISIAE RNA | ACTIVE INGREDIENT | J17GBZ5VGX | 1 | |
| SILICON DIOXIDE | ACTIVE INGREDIENT | ETJ7Z6XBU4 | 1 | |
| SILYBUM MARIANUM SEED | ACTIVE INGREDIENT | U946SH95EE | 1 | |
| SOMATROPIN | ACTIVE INGREDIENT | NQX9KB6PCL | 1 | |
| ZINC SULFATE HEPTAHYDRATE | ACTIVE INGREDIENT | N57JI2K7WP | 1 | |
| ACHILLEA MILLEFOLIUM | ACTIVE MOIETY | 2FXJ6SW4PK | 1 | |
| ARNICA MONTANA | ACTIVE MOIETY | O80TY208ZW | 1 | |
| CINCHONA OFFICINALIS BARK | ACTIVE MOIETY | S003A158SB | 1 | |
| GINKGO | ACTIVE MOIETY | 19FUJ2C58T | 1 | |
| LECITHIN, SOYBEAN | ACTIVE MOIETY | 1DI56QDM62 | 1 | |
| PHOSPHORIC ACID | ACTIVE MOIETY | E4GA8884NN | 1 | |
| PORK BRAIN | ACTIVE MOIETY | 466251J72G | 1 | |
| SACCHAROMYCES CEREVISIAE RNA | ACTIVE MOIETY | J17GBZ5VGX | 1 | |
| SILICON DIOXIDE | ACTIVE MOIETY | ETJ7Z6XBU4 | 1 | |
| SILYBUM MARIANUM SEED | ACTIVE MOIETY | U946SH95EE | 1 | |
| SOMATROPIN | ACTIVE MOIETY | NQX9KB6PCL | 1 | |
| ZINC CATION | ACTIVE MOIETY | 13S1S8SF37 | 1 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Products#
Every source-derived product name is available through these pages.
- Brain Power
- Arnica montana, Brain suis, Carduus marianus, Cinchona officinalis, Ginkgo biloba, HGH, Lecithin, Millefolium,
- ARNICA MONTANA
- PORK BRAIN
- SILYBUM MARIANUM SEED
- CINCHONA OFFICINALIS BARK
- GINKGO
- SOMATROPIN
- LECITHIN, SOYBEAN
- ACHILLEA MILLEFOLIUM
- PHOSPHORIC ACID
- SILICON DIOXIDE
- ZINC SULFATE HEPTAHYDRATE
- ZINC CATION
- WATER
- ALCOHOL
- GLYCERIN
- SACCHAROMYCES CEREVISIAE RNA
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 50845-0056 | 50845-0056-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ARNICA MONTANA | O80TY208ZW | ACTIB |
| PORK BRAIN | 466251J72G | ACTIB |
| SILYBUM MARIANUM SEED | U946SH95EE | ACTIB |
| CINCHONA OFFICINALIS BARK | S003A158SB | ACTIB |
| GINKGO | 19FUJ2C58T | ACTIB |
| SOMATROPIN | NQX9KB6PCL | ACTIB |
| LECITHIN, SOYBEAN | 1DI56QDM62 | ACTIB |
| ACHILLEA MILLEFOLIUM | 2FXJ6SW4PK | ACTIB |
| PHOSPHORIC ACID | E4GA8884NN | ACTIB |
| SILICON DIOXIDE | ETJ7Z6XBU4 | ACTIB |
| ZINC SULFATE HEPTAHYDRATE | N57JI2K7WP | ACTIM |
| WATER | 059QF0KO0R | IACT |
| ALCOHOL | 3K9958V90M | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| SACCHAROMYCES CEREVISIAE RNA | J17GBZ5VGX | ACTIB |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, CHEWABLE / ORAL | 12 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / TOPICAL | 561 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TRANSDERMAL | 90 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / OPHTHALMIC | 0.88 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / NASAL | 20 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAVENOUS | 33750 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY, METERED / NASAL | 13 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / BUCCAL | 679 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, FILM COATED / ORAL | 1.55 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAVENOUS | 6405 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TOPICAL | 2445 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / OPHTHALMIC | 0.5 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SUSPENSION / SUBCUTANEOUS | 1.6 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET / PERIODONTAL | 0.53 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / SUBCUTANEOUS | 149 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / OPHTHALMIC | 58 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / VAGINAL | 227.9 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / AURICULAR (OTIC) | 25 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 225 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | JELLY / VAGINAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYSTEM / TOPICAL | 18144 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / TOPICAL | 1720 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / OPHTHALMIC | 12 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DOUCHE / VAGINAL | 1 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / NASAL | 10 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / SUBCUTANEOUS | 450 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / DENTAL | 12.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / INTRAVENOUS | 4000 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / TRANSDERMAL | 306.2 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM, AUGMENTED / TOPICAL | 55 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SHAMPOO / TOPICAL | 714 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GUM, CHEWING / BUCCAL | 230 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TRANSDERMAL | 49.37 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / RECTAL | 0.35 %v/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / AURICULAR (OTIC) | 63.64 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TOPICAL | 500 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / SUBCUTANEOUS | 15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, COATED / ORAL | 14.21 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY / NASAL | 22.3 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE / ORAL | 3487 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / ORAL | 750 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | AEROSOL, FOAM / TOPICAL | 21 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVENOUS | 92 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / TOPICAL | 2.5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / DENTAL | 15 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / RESPIRATORY (INHALATION) | 26664 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, COATED / ORAL | 1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAVENOUS | 15 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / TOPICAL | 561 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | JELLY / VAGINAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET / ORAL | 42 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE, DENTIFRICE / DENTAL | 18 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, EXTENDED RELEASE / ORAL | 7 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOAP / TOPICAL | 0.76 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SWAB / TOPICAL | 2250 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / BUCCAL | 34 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 2c034314-8675-48ab-b940-3389b1d4d41c | ec46d849-39d2-4f46-abec-24d733a1183d | 2026-05-15 | Warnings | 2c034314-8675-48ab-b940-3389b1d4d41c ec46d849-39d2-4f46-abec-24d733a1183d |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.